Literature DB >> 3746545

Effect of maturation on oral breathing in sleeping premature infants.

M J Miller, W A Carlo, K P Strohl, A A Fanaroff, R J Martin.   

Abstract

To evaluate the influence of postnatal maturation on oral breathing, we measured nasal and oral ventilation during sleep and the ventilatory response to nasal occlusion in 11 preterm infants. Studies were repeated at 31-32, 33-34, and 35-36 weeks postconceptional age. Premature infants had rare episodes of spontaneous oronasal breathing during sleep. The frequency of oral breathing in response to nasal occlusion increased with advancing postconceptional age, from 8% +/- 8% at 31-32 weeks to 26% +/- 18% at 33-34 weeks and 28% +/- 33% at 35-36 weeks. Oral breathing in preterm infants, unlike that in term infants, was characterized by intermittent airway obstruction leading to a significant decrease in respiratory rate, tidal volume, minute ventilation, and tcpo2 (P less than 0.005). When inspiratory (Rl) and expiratory (RE) resistances during nasal and oral breathing were compared, Rl increased from 41 +/- 30 to 234 +/- 228 (P less than 0.004) and RE from 62 +/- 16 to 145 +/- 43 cm H2O X L-1 X sec (P less than 0.004). The ability of preterm infants to use the oral route of breathing thus increases with advancing postnatal maturation, but its effectiveness may remain limited by high oral airway resistance.

Entities:  

Mesh:

Year:  1986        PMID: 3746545     DOI: 10.1016/s0022-3476(86)80134-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  2 in total

Review 1.  Oxygen administration in infants.

Authors:  B Frey; F Shann
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-03       Impact factor: 5.747

Review 2.  Palatal development of preterm and low birthweight infants compared to term infants -- What do we know? Part 3: discussion and conclusion.

Authors:  Ariane Hohoff; Heike Rabe; Ulrike Ehmer; Erik Harms
Journal:  Head Face Med       Date:  2005-11-02       Impact factor: 2.151

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.